Identification and clinical implications of recurrent PAX5::MLLT3 fusion in lymphoid blastic phase chronic myeloid leukemia
Hematology
DOI:
10.1111/ijlh.14245
Publication Date:
2024-02-23T08:15:55Z
AUTHORS (9)
ABSTRACT
The data that support the findings of this study are available on request from corresponding author. not publicly due to privacy or ethical restrictions. Supplementary Table 1 result RNA sequencing for PAX5-MLLT3 fusion gene. 2 Clinical characteristics four patients genes. Please note: publisher is responsible content functionality any supporting information supplied by authors. Any queries (other than missing content) should be directed author article.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (12)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....